Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19

Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E15-E17. doi: 10.1093/ehjcvp/pvac010.

Authors

Luis Ortega-Paz¹, Mattia Galli², Dominick J Angiolillo¹

Affiliations

¹ Division of Cardiology, University of Florida College of Medicine, 5th floor, ACC Building, 655 West 8th Street, Jacksonville, FL 32209, USA.
² Catholic University of the Sacred Heart, Rome, Italy.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / administration & dosage
COVID-19*
Humans
Randomized Controlled Trials as Topic
SARS-CoV-2
Venous Thromboembolism* / drug therapy

Substances

Anticoagulants